The Expression Level and Clinical Significance of Long Non-Coding RNA SNHG3 in Gastric Cancer

Zhang Zilong,Xiong Bin,Pang Dianfu,Zhang Kenan
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.03.039
2018-01-01
Abstract:Objective To explore the expression and the clinical significance of long non-coding RNA (lncRNA) SNHG3 in gastric cancer.Methods TCGA data were used to analyze the expression of SNHG3 in 35 samples of para-cancerous tissues,56 samples of stage Ⅰ gastric cancer,123 samples of stage Ⅱ gastric cancer,169 samples of stage Ⅲ gastric cancer and 41 samples of stage Ⅳ gastric cancer.Kaplan-Meier plotter data was used to explore the association between SNHG3 expression and survival rates in patients with gastric cancer.Bioinformatics was used to analyze the biological processes and signaling pathways which were influenced by SNHG3 co-expression genes.Results SNHG3 was significantly overexpressed in stage Ⅰ gastric cancer (124.40 ± 10.51,P =0.034),stage Ⅱ gastric cancer (128.10 ± 9.88,P =0.003),stage Ⅲ gastric cancer (136.40 ± 7.55,P =0.000),and stage Ⅳ gastric Cancer (125.10 ± 13.34,P=0.004) compared to para-cancerous tissues (67.16 ±8.19),and gastric cancer patients with high SNHG3 expression had a shorter survival time.Bioinformatics predictions showed that SNHG3 was widely involved in a number of biological processes including RNA splicing,electronic respiratory chain transmission,mRNA processing,extracellular matrix organization,cell adhesion,skeletal system development,collagen catabolism,fatty acid metabolism,splicing complexes,cancer pathways,phosphatidylinositol 3 kinase (PI3K)-protein kinase B (Akt) signaling pathway,Rap1 signaling pathway,and Hippo signaling pathway.Conclusion lncRNA SNHG3 is upregulated in gastric cancer.The survival time of patients with high SNHG3 expression is short.
What problem does this paper attempt to address?